Latest news with #JohnSunil
Zawya
07-08-2025
- Business
- Zawya
Burjeel Holdings reports 129% increase in Q2'25 net profit
Burjeel Holdings PLC (Burjeel' or the Group) today announced its net profit surged 128.9% to AED 148 million in Q2'25, reflecting margin expansion, enhanced operating leverage, and asset optimization. In H1'25, net profit rose 10.6% to AED 187 million. According to Burjeel's financial results for the three-month and six-month periods ended 30 June 2025, the hospitals segment continued to drive Group performance, contributing 89% of total revenue in Q2'25. Revenue grew 17.3% to AED 1,245 million, supported by strong growth in patient volumes and sustained demand for complex care services. Burjeel Holdings delivered strong top-line growth of 18.7% to AED 1,403 million in Q2'25, driven by a 12.1% increase in patient footfall, higher patient yield, and the continued ramp-up of newly launched facilities across the network. Revenue in H1'25 rose 12.2% to AED 2,677 million, with total patient visits reaching 3.4 million. EBITDA rose 59.4% to AED 306 million in Q2'25, fueled by strong revenue growth, enhanced physician productivity, and better performance across recently ramped-up assets. John Sunil, Chief Executive Officer of Burjeel Holdings, said: 'The second quarter delivered exceptionally strong results, with 19% revenue growth driven by a 12% increase in patient footfall and improved yield. EBITDA rose by 59%, accompanied by a margin uplift to 22%. This robust performance significantly strengthened the first-half outcome, underscoring Burjeel Holdings' resilience and long-term sustainable growth.''
Khaleej Times
07-08-2025
- Business
- Khaleej Times
Burjeel net profit surges 128.9% in the second quarter
Burjeel Holdings delivered strong top-line growth of 18.7 per cent to Dh1,403 million in Q2'25, driven by a 12.1 per cent increase in patient footfall, higher patient yield, and the continued ramp-up of newly launched facilities across the network, the super-specialty healthcare services provider announced on Thursday. Net profit surged 128.9 per cent to Dh148 million in Q2'25, reflecting margin expansion, enhanced operating leverage, and asset optimisation. In H1'25, net profit rose 10.6 per cent to Dh187 million. Ebitda rose 59.4 per cent to Dh306 million in Q2'25, fuelled by strong revenue growth, enhanced physician productivity, and better performance across recently ramped-up assets. This includes Dh72 million in gains from lease liability derecognition following the Dubai Medeor Hospital acquisition. The Ebitda margin expanded 5.6 p.p. to 21.8 per cent. In H1'25, Ebitda increased 14.2 per cent to Dh487 million, with a margin of 18.2 per cent. Revenue in H1'25 rose 12.2 per cent to Dh2,677 million, with total patient visits reaching 3.4 million. Oncology remained a core growth driver, with revenue rising 36.7 per cent in Q2'25 and 38.1 per cent in H1'25, underpinned by oncology network expansion and improved conversion in surgical and advanced therapies. Other specialties also recorded solid gains in H1'25, including urology (+18 per cent), emergency medicine (+17 per cent), cardiology (+16 per cent), and gastroenterology (+13 per cent). John Sunil, CEO of Burjeel Holdings, was optimistic about maintaining strong momentum through the second half. 'We continue to target mid-teens revenue growth for the year, supported by the ramp-up of new assets and strategic expansion in both the UAE and Saudi Arabia,' he said. A key focus is making sure that Burjeel's new centres and services are launched smoothly and begin contributing at full potential. 'Major investments in specialised care, technology, and new geographies do not translate into financial returns overnight. But the strategy we have been executing is absolutely the right one, and this quarter's results are a clear example of how our growth strategy and investments in complex care are beginning to yield measurable financial results,' Sunil said. Inpatient footfall rose 17.7 per cent in Q2'25, reflecting strong demand across key specialties and a ramp-up in elective surgeries post-Ramadan. Outpatient footfall grew 12.0 per cent in Q2'25, accelerating from 5.2 per cent in Q1, driven by primary care and physiotherapy centers, along with robust demand in oncology, pediatrics, ophthalmology, and family medicine. Utilisation improved to 68 per cent, up from 65 per cent in Q1'25, enabled by optimised hiring and scaling of clinical teams. The Hospitals segment continued to drive group performance, contributing 89 per cent of total revenue in Q2'25. Revenue grew 17.3 per cent to Dh1,245 million, supported by strong growth in patient volumes and sustained demand for complex care services. Segment Ebitda rose by 40.6 per cent, led by strong performance across key hospitals. Operating cash flow increased 8.1 per cent YoY in H1'25, driven by improved operational performance and disciplined working capital management. Maintenance capex remained in line with guidance, while growth capex totalled Dh403 million, driven by strategic M&A activities and ongoing network expansion. Free cash flow conversion improved to 54 per cent in H1'25. In May 2025, the Group declared a full-year dividend of Dh170 million for FY2024, representing 47 per cent of net profit. Cost control was a key contributor to the company's performance. 'Even with 143 new physicians onboarded over the past year, we were able to optimise personnel costs through better workforce planning and clinical scheduling. We also brought overheads down by 7 per cent quarter-on-quarter and over 13 per cent compared to Q4, by normalising spend and embedding stronger cost discipline across the group. These efforts, alongside strong top-line growth, drove a significant improvement in margins,' Sunil said. The Trust Fertility Center, now the largest in the UAE, broke even within six months and has served over 1,800 unique patients with outcomes well above global benchmarks. 'It plays a key role in our women's health platform and aligns with the UAE's national fertility strategy. Looking ahead, we're replicating this model in Al Ain and Dubai, while continuing to invest in precision medicine, AI-enabled care, and complex specialties,' Sunil said.
Zawya
24-07-2025
- Health
- Zawya
Al Dahir Community celebrates surgical integration milestone at Burjeel Day Surgery Center
Al Ain: To celebrate the successful integration of advanced surgical services at the Burjeel Day Surgery Center (BDSC) in Al Dhahir, a special community gathering was held, attended by community leaders, prominent families, senior dignitaries, and the youth of the Al Ain region. A key milestone in the center's growth, the event highlighted its expanded role in bringing specialized healthcare closer to underserved areas of Al Ain. The celebration took place in the presence of H.E. Dr. Sultan Al Neyadi, UAE Astronaut and Minister of State for Youth Affairs. His participation emphasized the alignment of BDSC's services with the UAE's vision for an accessible and connected healthcare ecosystem. During the event, local community leaders shared personal experiences and praised the impact of the center in improving access to quality care. Senior leadership from Burjeel Holdings, including Dr. Shamsheer Vayalil, Founder and Chairman; Mr. John Sunil, CEO; and Mr. Omran Al Khoori, Member of the Board of Directors, also graced the occasion. The gathering also marked the inauguration of the second phase of BDSC's Operating Theaters. This expansion reflects the center's commitment to enhancing the quality and efficiency of healthcare services provided to citizens and residents of Al Ain, particularly the local communities in and around the Al Dhahir area. With this development, the facility is now fully equipped and operational for performing a wide range of surgical procedures. 'This milestone reflects our commitment to building healthcare systems around the needs of people and communities. The successful integration of surgical services at BDSC will enhance the offerings for the community. We are proud of the opportunity to work in line with the vision of our leadership to improve healthcare experiences across Al Ain,' said Dr. Aysha Almahri, CEO, Al Ain Region, Burjeel Holdings. Since its inception in May 2024, BDSC has evolved into a comprehensive surgical facility, offering a range of day surgeries across key specialties. From diagnostics to surgical interventions, the center now delivers a full suite of services, minimizing the need for patients to travel long distances for care. It offers specialized services in Orthopedics, ENT, General Surgery, Urology, Gynecology, Endoscopic Surgery, and more. The surgical unit is supported by board-certified doctors, rehabilitation experts, and modern diagnostic technology, and complex cases continue to be referred through Burjeel's broader network, ensuring seamless continuity of care. 'Our enhanced capabilities mean patients can now receive the care they need, quickly, safely, and close to home. We are proud to be a trusted partner for the community and will continue expanding services in response to local needs,' said Dr. Mohamed Hassan Abbass Hassan Elshamsy, Medical Director and Consultant in Ophthalmology at BDSC, Al Dhahir. The event also served as a platform to reinforce future plans to expand services at the center, including the potential addition of emergency and more complex care offerings.
Zawya
24-06-2025
- Business
- Zawya
Burjeel Holdings supports regional growth via $46.3mln acquisition deal
Burjeel Holding has acquired the Medeor 24x7 Hospital building in Dubai for AED 170 million, according to a press release. The acquisition aligns with the group's long-term strategy to enhance operational control, reduce fixed lease liabilities, and strengthen its asset base in strategic locations. Located near BurJuman, the medical facility was operated under a long-term lease with a remaining rental commitment of approximately AED 343 million over the next 15 years. The acquisition eliminates that lease liability and grants Burjeel full ownership of the high-performing facility. Meanwhile, Burjeel Holdings will be able to ensure uninterrupted operations, preserve brand equity, and avoid relocation costs. It also enhances operational flexibility for future service expansion and infrastructure upgrades. The hospital's strong patient volumes and central location support Burjeel Holdings' regional growth objectives, particularly in Dubai and the Northern Emirates. The CEO of Burjeel Holdings, John Sunil, said: 'By transitioning from leasehold to ownership in a key market, we reinforce our operational resilience and strengthen our platform for growth.' Medeor 24x7 Hospital, founded in 2015, is a JCI-accredited multi-speciality facility offering care in areas such as maternity, congenital surgery, cardiology, pulmonology, urology, dialysis, critical care, gastroenterology, and advanced laparoscopic and gynecological procedures. Burjeel Holdings recently launched four specialized mental health centers under its Alkalma mental health and wellbeing platform by integrating Aspris Healthcare facilities. All Rights Reserved - Mubasher Info © 2005 - 2022 Provided by SyndiGate Media Inc. (
Yahoo
24-06-2025
- Business
- Yahoo
Burjeel announces acquisition of Medeor 24×7 Hospital in Dubai
Burjeel has acquired the Medeor 24x7 Hospital building located in Dubai in a deal valued at Dh170m ($46.28m) for optimising long-term cost structure. This strategic decision is in line with the group's strategy to improve operational control and minimise fixed lease liabilities. Situated near BurJuman in Bur Dubai, the Medeor 24x7 Hospital operated under a long-term lease earlier with a remaining commitment of Dh343m over the next 15 years. The latest acquisition removes a substantial fixed rental liability. The acquisition grants Burjeel full control over the hospital's operations, ensuring continuity and protecting the brand's equity. It also eliminates the risks associated with potential relocation, providing operational flexibility for future expansions and service diversification. Its prime location and robust patient volumes support Burjeel's growth plans in Dubai and the Northern Emirates. These regions are identified as key areas for increasing presence due to strong demographic demand and service scalability. Burjeel Holdings CEO John Sunil said: "By transitioning from leasehold to ownership in a key market, we reinforce our operational resilience and strengthen our platform for growth. 'Dubai, along with the Northern Emirates, remains a central focus of our expansion strategy, and securing full control of this asset enables us to deepen our presence and better serve these high-demand markets." Medeor 24x7 Hospital, established in 2015, is a multi-specialty family hospital offering services including congenital malformation surgeries of the brain and spine, mother and childcare, cardiology, urology, pulmonology. It is accredited by the Joint Commission International and features a laboratory accredited by the College of American Pathologists. The move comes after Burjeel has inaugurated four new centres under its Alkalma mental health and well-being platform to broaden access to specialised mental healthcare. "Burjeel announces acquisition of Medeor 24×7 Hospital in Dubai" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
